487 related articles for article (PubMed ID: 33432169)
1. Aneuploidy as a promoter and suppressor of malignant growth.
Vasudevan A; Schukken KM; Sausville EL; Girish V; Adebambo OA; Sheltzer JM
Nat Rev Cancer; 2021 Feb; 21(2):89-103. PubMed ID: 33432169
[TBL] [Abstract][Full Text] [Related]
2. Role of aneuploidy in the carcinogenic process: Part 3 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases.
Tweats D; Eastmond DA; Lynch AM; Elhajouji A; Froetschl R; Kirsch-Volders M; Marchetti F; Masumura K; Pacchierotti F; Schuler M
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403032. PubMed ID: 31699349
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi YN; Qi WC; Xia BR; Lou G; Jin WL
Front Immunol; 2021; 12():697083. PubMed ID: 34295338
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
[TBL] [Abstract][Full Text] [Related]
5. MHC class I down regulation, tumour escape from immune surveillance and design of therapeutic strategies.
Bubeník J
Folia Biol (Praha); 2005; 51(1):1-2. PubMed ID: 15783085
[No Abstract] [Full Text] [Related]
6. Context is everything: aneuploidy in cancer.
Ben-David U; Amon A
Nat Rev Genet; 2020 Jan; 21(1):44-62. PubMed ID: 31548659
[TBL] [Abstract][Full Text] [Related]
7. Aneuploidy and tumorigenesis in Drosophila.
Milán M; Clemente-Ruiz M; Dekanty A; Muzzopappa M
Semin Cell Dev Biol; 2014 Apr; 28():110-5. PubMed ID: 24641887
[TBL] [Abstract][Full Text] [Related]
8. Humanized Mice for the Study of Immuno-Oncology.
De La Rochere P; Guil-Luna S; Decaudin D; Azar G; Sidhu SS; Piaggio E
Trends Immunol; 2018 Sep; 39(9):748-763. PubMed ID: 30077656
[TBL] [Abstract][Full Text] [Related]
9. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Delfortrie S; Pinte S; Mattot V; Samson C; Villain G; Caetano B; Lauridant-Philippin G; Baranzelli MC; Bonneterre J; Trottein F; Faveeuw C; Soncin F
Cancer Res; 2011 Dec; 71(23):7176-86. PubMed ID: 22037871
[TBL] [Abstract][Full Text] [Related]
10. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis.
Holland AJ; Cleveland DW
Nat Rev Mol Cell Biol; 2009 Jul; 10(7):478-87. PubMed ID: 19546858
[TBL] [Abstract][Full Text] [Related]
11. Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Gondhowiardjo SA; Handoko ; Jayalie VF; Apriantoni R; Barata AR; Senoaji F; Utami IJW; Maubere F; Nuryadi E; Giselvania A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911646
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.
Garcia-Gomez A; Rodríguez-Ubreva J; Ballestar E
Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540
[TBL] [Abstract][Full Text] [Related]
13. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
14. The impact of mitotic errors on cell proliferation and tumorigenesis.
Levine MS; Holland AJ
Genes Dev; 2018 May; 32(9-10):620-638. PubMed ID: 29802124
[TBL] [Abstract][Full Text] [Related]
15. The chromosomal basis of cancer.
Duesberg P; Li R; Fabarius A; Hehlmann R
Cell Oncol; 2005; 27(5-6):293-318. PubMed ID: 16373963
[TBL] [Abstract][Full Text] [Related]
16. A new perspective on the immune escape mechanism in HCC: onco-foetal reprogramming.
Chew SC; Choo SY; Chow PK
Br J Cancer; 2021 Jun; 124(12):1897-1899. PubMed ID: 33767421
[TBL] [Abstract][Full Text] [Related]
17. How aneuploidy affects metabolic control and causes cancer.
Rasnick D; Duesberg PH
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):621-30. PubMed ID: 10359645
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of human cancer.
Böck BC; Stein U; Schmitt CA; Augustin HG
Cancer Res; 2014 Sep; 74(17):4671-5. PubMed ID: 25136075
[TBL] [Abstract][Full Text] [Related]
19. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
20. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
